According to the Zhitong Finance App, Guobang Pharmaceutical (605507.SH) released its report for the first quarter of 2025. In the first quarter, the company achieved revenue of 1.44 billion yuan, an increase of 7.57% over the previous year. Net profit attributable to shareholders of listed companies was 215 million yuan, up 8.17% year on year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 204 million yuan, an increase of 5.60% over the previous year.

Zhitongcaijing · 04/15 08:49
According to the Zhitong Finance App, Guobang Pharmaceutical (605507.SH) released its report for the first quarter of 2025. In the first quarter, the company achieved revenue of 1.44 billion yuan, an increase of 7.57% over the previous year. Net profit attributable to shareholders of listed companies was 215 million yuan, up 8.17% year on year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 204 million yuan, an increase of 5.60% over the previous year.